Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apyrase is a calcium- or magnesium-activated enzyme that catalyzes the sequential hydrolysis of nucleoside triphosphates (NTPs), such as ATP, to their corresponding diphosphates (NDPs) and then to monophosphates (NMPs), releasing inorganic phosphate at each step. It is found in all eukaryotes and some prokaryotes. In blood-feeding arthropods' saliva, they inhibit host platelet aggregation by degrading extracellular ADP—a key mediator of platelet activation—thus facilitating blood feeding. In biotechnology, apyrases are used for degrading unincorporated nucleotides during DNA sequencing reactions such as pyrosequencing and serve as tools for studying purinergic signaling.
Catalyzes the sequential hydrolysis of nucleoside triphosphates (NTPs) to their corresponding diphosphates (NDPs) and then to monophosphates (NMPs), releasing inorganic phosphate at each step.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apyrase (None).